Palifermin-induced acral erythrodysaesthesia variant in the treatment of acute myeloid leukaemia
β Scribed by Olivia Milne; Briony Cutts; Catriona McLean; Douglas Gin
- Book ID
- 108929013
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 351 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0004-8380
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Clofarabine is a second generation nucleoside analogue. It inhibits DNA repair and activates the mitochondrial apoptotic pathway leading to cell death. __In vitro__ clofarabine has demonstrated synergy with daunorubicin and AraβC and in phase II clinical trials has shown promising activ
Differentiation inducing agents in double and triple combinations can induce differentiation in primary culture of more than 80% of blast cells from some AML patients. In the present study, the interactions between these differentiating agents have been analysed using Berenbaum's general algebraic s
Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per